Submit to Medicina Review for Medicina Propose a Special Issue

Journal Menu

Journal Browser

► Journal Browser

Special Issue "Latest Advances in the Treatment of Sinus and Nasal Diseases"

Special Issue Editors
Special Issue Information
Keywords
Published Papers

A special issue of Medicina (ISSN 1648-9144).

Deadline for manuscript submissions: closed (30 November 2019) | Viewed by 30293

Share This Special Issue

Special Issue Editor

Dr. Eng Ooi

E-Mail Website
Guest Editor

1. Head of the Otolaryngology Head and Neck Surgery Unit at Flinders Medical Centre, Adelaide 5001, Australia
2. Associate Professor, College of Medicine and Public Health, Flinders University, Adelaide 5001, Australia
Interests: sinusitis; immunology; rhinitis; sleep apnoea; oncology and carcinogenesis; airway and voice disorders; surgical education and simulation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

There have been significant advances in the management of sinus and nasal diseases, from understanding the pathophysiology and diagnosis of chronic rhinosinusitis to the development of new techniques and technologies with the expansion of endoscopic sinus surgery to areas beyond the paranasal sinuses.

Diseases of the paranasal sinuses extends to adjacent areas such as the orbit and skull base, affecting the patient’s quality of life. Furthermore, chronic rhinosinusitis remains a heterogenous and complex disease with emerging research on the microbiome, innate immunity and the role of new therapies, such as immunotherapy.

Endoscopic sinus surgery has also improved outcomes for patient with chronic rhinosinusitis. However, controversy remains about the extent of sinus surgery and its benefits on the quality of life of patients. The expanded endonasal approach has also allowed the treatment of diseases of the skull base, orbit and brain.

Therefore, the purpose of this Special Issue is to review current advancements and controversies in the treatment of patients with sinus and nasal diseases with a focus on chronic rhinosinusitis, its effects on patient’s quality of life and the expanded endoscopic surgical approaches to pathology beyond the paranasal sinuses.

Prof. Dr. Eng Ooi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

Rhinosinusitis
Nasal polyps
Rhinology
Sinusitis/therapy
Sinusitis/microbiology
Sinusitis/physiopathology
Immunotherapy
Endoscopy/instrumentation
Skull base neoplasms
Cerebrospinal fluid leak
Orbital cellulitis
Pituitary gland/surgery
Treatment outcomes
Quality of life
Sleep
Severe chronic upper airway disease

Published Papers (6 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Review, Other

10 pages, 448 KiB

Open AccessArticle

The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study

and

Medicina 2019, 55(6), 306; https://doi.org/10.3390/medicina55060306 - 25 Jun 2019

Cited by 21 | Viewed by 2634

Abstract

Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common form of cancer worldwide, with approximately 630,000 new cases diagnosed each year. The development of low-cost and non-invasive tools for the detection of HNSCC using volatile organic compounds (VOCs) in the breath could potentially improve patient care. The aim of this study was to investigate the feasibility of selected ion flow tube mass spectrometry (SIFT-MS) technology to identify breath VOCs for the detection of HNSCC. Materials and Methods: Breath samples were obtained from HNSCC patients (N = 23) and healthy volunteers (N = 21). Exhaled alveolar breath samples were collected into FlexFoil^® PLUS (SKC Limited, Dorset, UK) sampling bags from newly diagnosed, histologically confirmed, untreated patients with HNSCC and from non-cancer participants. Breath samples were analyzed by Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS) (Syft Technologies, Christchurch, New Zealand) using Selective Ion Mode (SIM) scans that probed for 91 specific VOCs that had been previously reported as breath biomarkers of HNSCC and other malignancies. Results: Of the 91 compounds analyzed, the median concentration of hydrogen cyanide (HCN) was significantly higher in the HNSCC group (2.5 ppb, 1.6–4.4) compared to the non-cancer group (1.1 ppb, 0.9–1.3; Benjamini–Hochberg adjusted p < 0.05). A receiver operating curve (ROC) analysis showed an area under the curve (AUC) of 0.801 (95% CI, 0.65952–0.94296), suggesting moderate accuracy of HCN in distinguishing HNSCC from non-cancer individuals. There were no statistically significant differences in the concentrations of the other compounds of interest that were analyzed. Conclusions: This pilot study demonstrated the feasibility of SIFT-MS technology to identify VOCs for the detection of HNSCC. Full article

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

► Show Figures

Figure 1

13 pages, 631 KiB

Open AccessArticle

Insights on Allergic Rhinitis Management from a Northern Cyprus Perspective and Evaluation of the Impact of Pharmacist-Led Educational Intervention on Patients’ Outcomes

and

Medicina 2018, 54(5), 83; https://doi.org/10.3390/medicina54050083 - 07 Nov 2018

Cited by 9 | Viewed by 3020

Abstract

Background and objective: the global prevalence of allergic rhinitis (AR) is rising and yet there is scarce information concerning the diagnosis, management and treatment patterns of AR in Northern Cyprus (NC). This study aims to provide a unique perspective on AR management as well as assessing the effectiveness of the pharmacist-led educational intervention for improving care of AR patients. Methods: across-sectional survey was carried out with community pharmacists (n = 70), patients (n = 138) and ear, nose and throat (ENT) specialists (n = 12) in NC. For a controlled interventional trial, trained pharmacists provided a brief education on management of AR and nasal spray technique for patients while other pharmacists provided the usual care. Quality of life (QoL) and other outcome measures on the perceived symptom severity of the two groups were compared after a 6-week period. Results: only 33.3% of the ear, nose and throat (ENT) specialists and 15.7% of the community pharmacists are aware of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. The majority of patients (63%) self-managed with over-the-counter medications. Nasal congestion (96.4%) is the most bothersome symptom and oral antihistamines are the most commonly purchased medications (51.4%), indicating a pattern of suboptimal management. The pharmacists-led educational intervention has resulted in statistically more significant improvement in regards to nasal congestion and QoL for the intervention group patients (p < 0.05). Conclusion: the current management of AR has not been in accordance with the ARIA guidelines in NC. An educational intervention of the pharmacists can enhance the symptom management and improve the QoL in patients with AR. Full article

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

► Show Figures

Graphical abstract

Review

Jump to: Research, Other

14 pages, 309 KiB

Open AccessReview

Invasive and Non-Invasive Fungal Rhinosinusitis—A Review and Update of the Evidence

Peter George Deutsch

Joshua Whittaker

and

Shashi Prasad

Medicina 2019, 55(7), 319; https://doi.org/10.3390/medicina55070319 - 28 Jun 2019

Cited by 106 | Viewed by 7774

Abstract

Fungal infections are a subset of infectious processes that an otolaryngologist is required to be familiar with. They can be encountered in otology, rhinology and head and neck surgery. The presence of fungal rhinosinusitis is well recognised by otolaryngologists, but the classifications and appropriate management are not so well understood. The prevalence of fungal sinus disease is thought to be have been increasing in recent decades There is speculation that this may be due to increased awareness, antibiotic overuse and increased use of immunosuppressant medications. Added to this, there has been a large amount published on the role of fungi as a causative organism in chronic rhinosinusitis. Given the importance of fungal rhinosinusitis in clinical practice, we aim to review the classification and current management strategies based on up-to-date literature. Full article

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

13 pages, 734 KiB

Open AccessReview

Inflammation and Endotyping in Chronic Rhinosinusitis—A Paradigm Shift

Sinead Ahern

and

Anders Cervin

Medicina 2019, 55(4), 95; https://doi.org/10.3390/medicina55040095 - 05 Apr 2019

Cited by 44 | Viewed by 5329

Abstract

Chronic rhinosinusitis (CRS) is a heterogeneous chronic inflammatory condition of the paranasal sinuses and nasal passage. It is characterized as inflammation of the sinonasal passage, presenting with two or more symptoms (nasal blockage, secretions, facial pain and headaches) for more than 12 weeks consecutively. The disease is phenotypically differentiated based on the presence of nasal polyps; CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Traditionally, CRSwNP has been associated with a type 2 inflammatory profile, while CRSsNP has been associated with a type 1 inflammatory profile. Extensive work in characterizing the inflammatory profiles of CRS patients has challenged this dichotomy, with great variation both between and within populations described. Recent efforts of endotyping CRS based on underlying pathophysiology have further highlighted the heterogeneity of the disease, revealing mixed inflammatory profiles coordinated by a number of inflammatory cell types. This review will highlight the current understanding of inflammation in CRS, and discuss the importance and impact of refining this understanding in the development of appropriate treatment options for CRS sufferers. Full article

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

► Show Figures

Figure 1

Other

Jump to: Research, Review

7 pages, 2363 KiB

Open AccessCase Report

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis

and

Medicina 2019, 55(7), 336; https://doi.org/10.3390/medicina55070336 - 03 Jul 2019

Cited by 20 | Viewed by 3888

Abstract

A 56-year-old man with severe asthma underwent bronchial thermoplasty (BT). However, his asthma exacerbated and hypereosinophilia developed 2 months later, thus necessitating oral corticosteroid (OCS) therapy. Six months after BT, a diagnosis of severe asthma with eosinophilic chronic rhinosinusitis (ECRS) was made and benralizumab treatment was initiated; the blood eosinophil count subsequently decreased and lung function improved, thereby permitting OCS dose tapering. Surprisingly, benralizumab both reduced nasal polyps and ameliorated ECRS. Thus, benralizumab may be a useful drug for the rapid treatment of severe asthma with ECRS, especially in patients with hypereosinophilia. Full article

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

► Show Figures

Graphical abstract

7 pages, 4257 KiB

Open AccessCase Report

Nasal Chondrosarcoma of the Lower Lateral Cartilage

Hannah B. Tan

and

Joanne Rimmer

Medicina 2019, 55(5), 128; https://doi.org/10.3390/medicina55050128 - 09 May 2019

Cited by 2 | Viewed by 6653

Abstract

Head and neck chondrosarcomas are incredibly rare with documented cases arising from skull base, maxilla, larynx, and nasal septum. We present the first reported case of chondrosarcoma arising from the lower lateral cartilage of the nose treated with surgical resection and primary reconstruction. [...] Read more.

(This article belongs to the Special Issue Latest Advances in the Treatment of Sinus and Nasal Diseases)

► Show Figures

Journal Menu

Journal Browser

Special Issue "Latest Advances in the Treatment of Sinus and Nasal Diseases"

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Published Papers (6 papers)

Research

Review

Other

Further Information

Guidelines

MDPI Initiatives

Follow MDPI